The Los Angeles Post
U.S. World Business Lifestyle
Today: April 07, 2025
Today: April 07, 2025

US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties

FILE PHOTO: A sign outside a Wuxi AppTec facility is pictured, in San Diego
July 02, 2024
Karen Freifeld - Reuters

By Karen Freifeld

(Reuters) -A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology companies including WuXi AppTec and BGI would give U.S. companies until 2032 to end work with the firms, extending the amount of time to find new partners.

The latest Biosecure Act also adds WuXi Biologics to a list of biotech companies of concern, according to a copy seen by Reuters. The other companies on the list are BGI, MGI, Complete Genomics and WuXi AppTec.

US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
Illustration picture of WuXi AppTec

The companies are largely contractors that do research and manufacturing work for pharmaceutical and biotech firms around the world.

The revised bill was introduced on Friday. A U.S. House of Representatives committee is expected to decide next week whether to move it forward, according to a House Committee on Oversight and Accountability spokesperson.

The committee markup, expected Wednesday, is a procedural step where they discuss and vote on the text of the bill. A similar Senate bill was approved by a committee there in March.

News of the proposed legislation has driven WuXi AppTec and WuXi Biologics shares down this year.

The bills are designed to keep Americans' personal health and genetic information from foreign adversaries and aim to push U.S. pharmaceutical and biotech companies to lessen their reliance on China for everything from drug ingredient manufacturing to early research.

"China has so much control of the market. We've got to start this shift," Rep. Brad Wenstrup said in an interview. But, he added, "we can't cut ourselves off and we don't now want China to cut us off, so we have to do this in a systematic way."

Wenstrup introduced the revised House bill with Rep. Raja Krishamoorthi.

Complete Genomics said it "is encouraged that policymakers understand the detrimental impacts to the U.S. biotech supply chain โ€“ and how the legislation would jeopardize the drug supply for millions of American patients." The company said it does not have access to personal DNA data and should be taken out of the bill.

Spokespeople for WuXi Biologics and WuXi AppTec said they had not seen the revised bill and could not comment on it. WuXi AppTec said the original bill relies on "misleading allegations and inaccurate assertions." MGI did not immediately respond to a request for comment.

The latest bill "highlights a key vulnerability in our global supply chain and importantly provides a reasonable timeframe for companies to decouple their reliance on China-based biomanufacturing," John Crowley, president of BIO, an industry association, said in a statement.

The association sent the results of a member survey to Congress on Wednesday. Of the 124 biopharmaceutical companies and biotechnology companies that responded, 79 percent had at least one contract or product agreement with a China-based or owned manufacturer.

The "vast majority" of business described in the survey is assumed to be with WuXi Biologics and WuXi AppTec, Crowley said in an interview.

Companies estimated it would take up to eight years to switch manufacturing partners, the survey found.

BGI Group said, as it has in the past, that it supports protecting Americans' personal data and did not have access to the data. It said the bill would drive BGI out of the U.S. and limit competition.

(Reporting by Karen Freifeld; Editing by Chizu Nomiyama, Michael Erman and Diane Craft)

Related Articles

Drugmakers sink after key FDA official ousted as Trump plans health overhaul โ€˜What kind of piece of sh*t uses when pregnant?โ€™: Young mother speaks out on fentanyl addiction Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug AI can rip you off. Here's how lawmakers in one state want to stop price discrimination
Share This

Popular

Business|MidEast|Political|Technology|US

Microsoft workers say they've been fired after 50th anniversary protest over Israel contract

Microsoft workers say they've been fired after 50th anniversary protest over Israel contract
Business|Economy|Political|Stock Markets|US

Trump threatens more tariffs on China as global markets plunge

Trump threatens more tariffs on China as global markets plunge
Americas|Business|Economy|Science|Technology|World

Chile has 28% more lithium than previous estimates, studies find

Chile has 28% more lithium than previous estimates, studies find
Americas|Business|Economy|World

Chile's Codelco boosts copper output, chairman bullish despite trade war

Chile's Codelco boosts copper output, chairman bullish despite trade war

Economy

Business|Economy|Political|US

White House economic advisor Miran encourages countries to approach Trump with offers to cut tariffs

White House economic advisor Miran encourages countries to approach Trump with offers to cut tariffs
Asia|Business|Economy|Finance|Political|Stock Markets|US

The Latest: Stocks sink globally as Trump pushes ahead with trade war

The Latest: Stocks sink globally as Trump pushes ahead with trade war
Business|Economy|Finance|Political|Stock Markets|US

Hear what Trump has to say amid sharp decline in market futures

Hear what Trump has to say amid sharp decline in market futures
Business|Economy|Finance|Political|Stock Markets|US

How actual โ€˜fake newsโ€™ caused a market whiplash

How actual โ€˜fake newsโ€™ caused a market whiplash

Access this article for free.

Already have an account? Sign In